Medications

Unituxin approved for deadly pediatric cancer

(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.

Neuroscience

New drug target for multiple sclerosis discovered

Scientists at the Centre for Addiction and Mental Health (CAMH) have discovered a promising new approach to treat multiple sclerosis (MS). In a new study, they've identified a previously unknown change in the spinal cord ...

Alzheimer's disease & dementia

Researchers tackle one of the biggest questions in dementia research

Researchers in Southampton are tackling one of the biggest questions in dementia research; why might current approaches in Alzheimer's trials be failing? The new study is published in the Journal of Pathology and funded by ...

Neuroscience

Targeted brain stimulation aids stroke recovery in mice

When investigators at the Stanford University School of Medicine applied light-driven stimulation to nerve cells in the brains of mice that had suffered strokes several days earlier, the mice showed significantly greater ...

Parkinson's & Movement disorders

Too much protein may kill brain cells as Parkinson's progresses

Scientists may have discovered how the most common genetic cause of Parkinson's disease destroys brain cells and devastates many patients worldwide. The study was partially funded by the National Institutes of Health's National ...

page 7 from 16